Assignee
PHARMAKEA INC
US·19 granted patents·7 pending applications·74 citations·filing 2014–2024
Top patents by PatentIndex Score
26 records- 0195US10150732B2Fluorinated lysyl oxidase-like 2 inhibitors and uses thereofPHARMAKEA INC·Filed 2017·Granted Dec 11, 2018·10 cites·24 claims
- 0293US9334261B2Autotaxin inhibitor compoundsPHARMAKEA INC·Filed 2015·Granted May 10, 2016·9 cites·17 claims
- 0392US9468628B2Autotaxin inhibitor compoundsPHARMAKEA INC·Filed 2016·Granted Oct 18, 2016·7 cites·15 claims
- 0492US9051320B1Methods for the treatment of metabolic disorders by a selective small molecule autotaxin inhibitorPHARMAKEA INC·Filed 2014·Granted Jun 9, 2015·23 cites·19 claims
- 0590US10570094B2Fluorinated lysyl oxidase-like 2 inhibitors and uses thereofPHARMAKEA INC·Filed 2018·Granted Feb 25, 2020·4 cites·21 claims
- 0690US9999615B2Autotaxin inhibitor compoundsPHARMAKEA INC·Filed 2016·Granted Jun 19, 2018·6 cites·20 claims
- 0788US10774069B2Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of makingPHARMAKEA INC·Filed 2017·Granted Sep 15, 2020·2 cites·9 claims
- 0888US10766860B2Lysyl oxidase-like 2 inhibitors and uses thereofPHARMAKEA INC·Filed 2016·Granted Sep 8, 2020·4 cites·11 claims
- 0986US10588900B2Quinolinone lysyl oxidase-like 2 inhibitors and uses thereofPHARMAKEA INC·Filed 2017·Granted Mar 17, 2020·2 cites·20 claims
- 1081US9926318B2Tetracyclic autotaxin inhibitorsPHARMAKEA INC·Filed 2014·Granted Mar 27, 2018·4 cites·17 claims
- 1180US11072585B2Fluorinated lysyl oxidase-like 2 inhibitors and uses thereofPHARMAKEA INC·Filed 2019·Granted Jul 27, 2021·1 cites·17 claims
- 1280US11058676B2Quinolinone lysyl oxidase-like 2 inhibitors and uses thereofPHARMAKEA INC·Filed 2019·Granted Jul 13, 2021·1 cites·22 claims
- 1379US2024415824A1Uses of a lysyl oxidase-like 2 inhibitorPHARMAKEA INC·Filed 2024·Application pending·0 cites
- 1468US9951026B2Heterocyclic vinyl autotaxin inhibitor compoundsPHARMAKEA INC·Filed 2014·Granted Apr 24, 2018·1 cites·19 claims
- 1566US11793797B2Uses of a lysyl oxidase-like 2 inhibitorPHARMAKEA INC·Filed 2017·Granted Oct 24, 2023·0 cites·15 claims
- 1664US2021177820A1Uses of a lysyl oxidase-like 2 inhibitorPHARMAKEA INC·Filed 2021·Application pending·0 cites
- 1762US11358936B2Lysyl oxidase-like 2 inhibitors and uses thereofPHARMAKEA INC·Filed 2020·Granted Jun 14, 2022·0 cites·11 claims
- 1860US11459309B2Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of makingPHARMAKEA INC·Filed 2020·Granted Oct 4, 2022·0 cites·5 claims
- 1950US2018162859A1Tetracyclic autotaxin inhibitorsPHARMAKEA INC·Filed 2018·Application pending·0 cites
- 2046US9850203B2Autotaxin inhibitor compoundsPHARMAKEA INC·Filed 2014·Granted Dec 26, 2017·0 cites·20 claims
- 2146US9714240B2Vinyl autotaxin inhibitor compoundsPHARMAKEA INC·Filed 2014·Granted Jul 25, 2017·0 cites·22 claims
- 2243US11345676B2Apoptosis signal-regulating kinase 1 (ASK 1) inhibitor compoundsPHARMAKEA INC·Filed 2018·Granted May 31, 2022·0 cites·17 claims
- 2342US2019192697A1Chemical probes of lysyl oxidask-like 2 and uses thereofPHARMAKEA INC·Filed 2017·Application pending·0 cites
- 2439US2018186755A1Lysyl oxidase-like 2 inhibitors and uses thereofPHARMAKEA INC·Filed 2016·Application pending·0 cites
- 2539US2018215727A1Lysyl oxidase-like 2 inhibitors and uses thereofPHARMAKEA INC·Filed 2016·Application pending·0 cites
- 2636US2017088520A1Deubiquitinase inhibitorsPHARMAKEA INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →